{"version":"https://jsonfeed.org/version/1","title":"BarbaraBoyd.com","home_page_url":"https://barbaraboyd.com","description":"BarbaraBoyd.com","author":{"name":"BarbaraBoyd.com"},"items":[{"id":"https://barbaraboyd.com/blog/f/alcoa-problem-hidden-in-plain-sight-disconnected-quality-system","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/11930\"/><p>Walk into almost any pharmaceutical manufacturing site that has been operating for more than fifteen years and you will find the same thing: multiple quality and laboratory systems that were each implemented to solve a s...</p>","url":"https://barbaraboyd.com/blog/f/alcoa-problem-hidden-in-plain-sight-disconnected-quality-system","title":"ALCOA+ Problem Hidden in Plain Sight:Disconnected Quality System","summary":"Walk into almost any pharmaceutical manufacturing site that has been operating for more than fifteen years and you will find the same thing: multiple quality and laboratory systems that were each implemented to solve a s...","date_modified":"2026-09-22T22:23:37Z"},{"id":"https://barbaraboyd.com/blog/f/what-fdas-growing-483-observation-trend-tells-us-about-ai-in-gmp","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/103434\"/><p>The pharmaceutical industry is in the middle of a complicated conversation about artificial intelligence. Vendors promise efficiency, speed, and transformation. Quality professionals are asking a harder question: how do ...</p>","url":"https://barbaraboyd.com/blog/f/what-fdas-growing-483-observation-trend-tells-us-about-ai-in-gmp","title":"What FDA's Growing 483 Observation Trend Tells Us About AI in GMP","summary":"The pharmaceutical industry is in the middle of a complicated conversation about artificial intelligence. Vendors promise efficiency, speed, and transformation. Quality professionals are asking a harder question: how do ...","date_modified":"2026-09-22T19:44:20Z"}]}